Introduction {#s1}
============

Cyclic adenosine 3',5'-monophosphate (cAMP) controls various physiological functions, such as the heart beat ([@bib89]), learning and memory ([@bib47]; [@bib56]), olfaction ([@bib44]), and fertilization ([@bib8]). cAMP is synthesized by adenylate cyclases (ACs) and degraded by phosphodiesterases (PDEs) ([@bib28]; [@bib31]; [@bib74]). Local cAMP signaling is achieved by targeting of signaling components to subcellular compartments and assembly of signaling complexes ([@bib83]). A prime example of a subcellular compartment is the cilium, where cAMP translates external stimuli into cellular responses ([@bib41]).

Cilia come in two different flavors: primary cilia and motile cilia. A prominent example of a motile cilium is the sperm flagellum that serves as a sensory antenna and propels sperm forward. cAMP-signaling pathways control different functions during the sperm's journey to the egg. The principal cAMP source in sperm, the bicarbonate- and Ca^2+^-sensitive soluble adenylate cyclase SACY ([@bib26]; [@bib33]; [@bib77]; [@bib86]), is activated by increasing bicarbonate concentrations ([@bib50]; [@bib81]) after sperm are released from the epididymis. Sperm lacking SACY are immotile, which causes male infertility ([@bib26]; [@bib33]; [@bib86]). The elevated cAMP levels activate protein kinase A (PKA) - the primary cAMP target in sperm ([@bib62]). PKA activation in turn accelerates the flagellar beat ([@bib33]; [@bib81]; [@bib86]). cAMP is also involved in a maturation process of sperm called capacitation that is essential for fertilizing the egg; stimulation of cAMP synthesis by bicarbonate seems to be required for protein tyrosine phosphorylation, which is a hallmark of capacitated sperm ([@bib79]). However, the molecular mechanisms underlying these cAMP-signaling pathways in sperm are not well understood.

Components of cAMP signaling have also been identified in immotile cilia, e.g. in the specialized cilium of mammalian olfactory neurons, where cAMP stimulates the electrical signal evoked by odorants ([@bib44]). Primary cilia also host several cAMP-signaling components ([@bib41]): the somatostatin 3 receptor (SSTR3), various adenylate cyclases (AC3, AC4, AC6, AC8), PKA, and Epac2 (*[e]{.ul}xchange [p]{.ul}rotein directly [a]{.ul}ctivated by [c]{.ul}AMP*) ([@bib5]; [@bib37]; [@bib45]; [@bib52]; [@bib63]). An important signaling pathway in primary cilia is controlled by Sonic hedgehog (Shh), which determines neuronal cell fate during development ([@bib15]; [@bib25]; [@bib36]). Shh signaling relies on PKA activation ([@bib57]; [@bib76]). However, the physiological function of cAMP signaling in primary cilia and the underlying molecular mechanisms are ill-defined.

Analyzing cAMP dynamics *in vivo* became feasible by the advent of genetically-encoded cAMP biosensors that rely on FRET (*[F]{.ul}örster [r]{.ul}esonance [e]{.ul}nergy [t]{.ul}ransfer*) ([@bib13]; [@bib34]; [@bib73]; [@bib84]). The most advanced cAMP sensors are based on the cyclic nucleotide-binding domain (CNBD) of Epac1/2 ([@bib59]; [@bib65]) or HCN channels ([@bib60]). The CNBD is sandwiched between the fluorescent donor CFP (cyan fluorescent protein) and the fluorescent acceptor YFP (yellow fluorescent protein). The K~D~ values of the Epac1/2- or HCN2-based cAMP sensors range between 1--15 µM ([@bib34]; [@bib73]; [@bib84]), suitable to detect basal cAMP concentrations and changes in cAMP levels in the micromolar range ([@bib11]). In some cell systems, these sensors were able to report a cAMP increase, but their sensitivity was not sufficient to determine basal cAMP levels ([@bib11]).

The analysis of cAMP dynamics in cilia and flagella is challenging for several reasons. First, the cAMP biosensor must be targeted to this cellular compartment; second, measuring low cAMP concentrations requires the affinity of the sensor to be high, in particular, in a subcellular compartment with only a few cAMP molecules present. Finally, quantitative characterization and calibration in cilia is technically demanding due to their small size compared to the cell soma.

Ca^2+^dynamics have been measured in primary cilia using genetically-encoded biosensors. These studies revealed that the cilium represents a unique Ca^2+^-signaling compartment that is functionally distinct from the cytoplasm ([@bib21]; [@bib22]). Whether cAMP signaling in cilia and flagella is also functionally distinct from the cytoplasm, is ill-defined.

Here, we describe a new FRET-based cAMP biosensor (mlCNBD-FRET) that is built from the CNBD of the bacterial *Mloti*K1 channel ([@bib61]) and binds cAMP with nanomolar affinity ([@bib20]; [@bib64]). This biosensor features unique characteristics that enable its application in solution, in cell lines, and *in vivo* using kinetic, fluorometric, and live-cell imaging techniques. To target the sensor to cilia and flagella, we designed a cilia-specific targeting approach, and we generated transgenic mice expressing mlCNBD-FRET exclusively in the sperm flagellum. Our results reveal that the dynamics of total and free cAMP levels in sperm and the cAMP dynamics in the midpiece and principal piece of the flagellum are distinctively different. We investigated the regulation of cAMP dynamics in sperm and obtained new insights into the Ca^2+^-dependent control of cAMP synthesis.

Results {#s2}
=======

Characterization of the mlCNBD-FRET protein {#s2-1}
-------------------------------------------

The CNBD from the bacterial *Mloti*K1 channel (mlCNBD) consists of a prototypical eight-stranded beta roll (β1--8) flanked by three alpha helices (αA-C, [Figure 1A,B](#fig1){ref-type="fig"}) ([@bib17]; [@bib20]; [@bib61]). A phosphate-binding cassette (PBC) that interacts with the sugar and phosphate moiety of the cyclic nucleotide is the most conserved feature of CNBDs ([Figure 1B](#fig1){ref-type="fig"}). Upon cAMP binding, mlCNBD undergoes a conformational change ([@bib71]). We fused two variants of the green fluorescent protein - citrine ([@bib30]) and cerulean ([@bib68]) - to the N- and C-terminus of mlCNBD to measure cAMP-induced conformational changes by FRET. Cerulean, the FRET donor, transfers energy to the FRET acceptor citrine. A histidine tag (His~10~) was fused to the C-terminus of cerulean ([Figure 1C](#fig1){ref-type="fig"}) to purify the protein via cobalt immobilized-metal affinity chromatography ([Figure 1D](#fig1){ref-type="fig"}). In size-exclusion chromatography, the mlCNBD-FRET protein eluted as a single peak with an apparent molecular mass of 67 kDa, close to the calculated molecular mass of 70.9 kDa ([Figure 1E](#fig1){ref-type="fig"}).10.7554/eLife.14052.003Figure 1.Generation and purification of mlCNBD-FRET.(**A**) Ribbon presentation of a single mlCNBD according to ([@bib71]). The first (Phe223) and the last amino acid (Arg349) are indicated. (**B**) Structural features of mlCNBD. Alpha helices (αA-C), beta rolls (β1--8), and the phosphate binding-cassette (PBC) are indicated. The arginine (**R**) crucial for cAMP-binding is boxed. (**C**) The mlCNBD-FRET biosensor. The sensor has been generated by fusing citrine and cerulean to the N- and C-terminus of mlCNBD, respectively. For purification, a His~10~ tag has been added to the C-terminus. (**D**) Purification of mlCNBD-FRET via cobalt immobilized-metal affinity chromatography. Representative elution profile for mlCNBD-FRET using a linear imidazole gradient. The absorption has been recorded at three different wavelengths (280 nm: protein, green; 433 nm: cerulean, black; 516 nm: citrine, red). The inset shows a representative Western blot for the purified mlCNBD-FRET and mlCNBD-FRET-R307Q protein, stained with an anti-His antibody. (**E**) Size-exclusion chromatography of the purified mlCNBD-FRET protein. Representative elution profile. The protein eluted in a main peak at 67 kDa (peak maximum), close to the expected molecular mass of 70.9 kDa. A minor peak was observed that eluted earlier and represents the void volume. Fractions indicated by the grey line have been used for analysis.**DOI:** [http://dx.doi.org/10.7554/eLife.14052.003](10.7554/eLife.14052.003)

Binding of cAMP to mlCNBD-FRET was measured in a spectrofluorometer. The two fluophores in the protein undergo FRET, indicating that they are in close proximity in the absence of cAMP ([Figure 2A](#fig2){ref-type="fig"}). Addition of cAMP decreased FRET: the cerulean emission at 475 nm increased, whereas the citrine emission at 529 nm decreased ([Figure 2A](#fig2){ref-type="fig"}). Thus, upon cAMP binding, the two fluorophores move further apart ([Figure 2B,C](#fig2){ref-type="fig"}). In the following, changes of the cerulean/citrine emission ratio (△F) are used; an increase of this ratio reflects a cAMP increase and vice versa. We characterized cAMP binding to mlCNBD-FRET by measuring the change in △F caused by increasing cAMP concentrations ([Figure 2D](#fig2){ref-type="fig"}). The dose-response relationship was fitted with a single binding-site model ([@bib20]). The K~D~ of mlCNBD-FRET for cAMP was 66 ± 15 nM (n = 5), similar to that for mlCNBD (68 ± 9 nM) ([@bib20]). This demonstrates that the two fluorophores do not interfere with cAMP binding, and that the sensor detects cAMP concentrations in the low to medium nanomolar range. Finally, a control mutant carrying an R307Q amino-acid exchange in the PBC that abolishes cAMP binding ([Figure 1B](#fig1){ref-type="fig"}) ([@bib7]; [@bib32]; [@bib53]; [@bib90]), did not respond to cAMP concentrations up to 1.5 μM ([Figure 2D](#fig2){ref-type="fig"}).10.7554/eLife.14052.004Figure 2.Characterization of the purified mlCNBD-FRET.(**A**) Fluorescence spectra of mlCNBD-FRET at 430 nm excitation before (black) and after addition of 10 μM cAMP (grey). (**B**) Schematic representation of the structural changes evoked by cAMP upon binding, FRET becomes smaller, indicating that cerulean and citrine move further apart. (**C**) Structural changes occurring after cAMP binding. The cAMP-free structure is shown in blue, the cAMP-bound structure is shown in green. Distances are presented in Ångstrom. (**D**) Binding of cAMP to mlCNBD-FRET (black) determined by fluorescence spectroscopy. Representative experiments showing an increase in the baseline-corrected cerulean/citrine emission ratio (△F) of mlCNBD-FRET (430 nm excitation) after cAMP binding. Data have been fitted using a single binding-site model (red line) ([@bib20]). As a control, mlCNBD-FRET-R307Q (red dots) has been used. Measurements have been performed using 1 μM protein. (**E**) Representative experiments showing an increase of △F of mlCNBD-FRET (430 nm excitation) after cGMP binding. Data has been fitted (see (**D**), red line). Measurements have been performed using 1 μM protein. (**F**) Normalized fluorescence spectra of mlCNBD-FRET (430 nm excitation) at different pH conditions. Spectra were normalized to the cerulean emission at 471 nm. (**G**) Normalized FRET (430 nm excitation, 529 nm emission) at different pH values. Data have been taken from measurements shown in (**F**) and are presented as mean ± S.D.; n = 3. (**H**) Kinetics of cAMP binding to mlCNBD-FRET measured using the stopped-flow technique. Different cAMP concentrations (in µM: 0.5, 1, 1.6, 2.5, 5, and 10) were mixed with the purified mlCNBD-FRET protein (2.5 μM) and the change in FRET was measured over time. Solid lines represent a global fit of a one-step model (see materials and methods) with the following parameters: k~on~ = 2.6 \*10^7^ M^-1^s^-1^ and k~off~ = 12.8 s^-1^.**DOI:** [http://dx.doi.org/10.7554/eLife.14052.004](10.7554/eLife.14052.004)

We also determined the cGMP sensitivity of mlCNBD-FRET: cGMP enhanced △F at a tenfold higher concentration than cAMP ([Figure 2E](#fig2){ref-type="fig"}). From the dose-response relationship, we determined for cGMP a K~D~ of 504 ± 137 nM (n = 6), which is similar to the K~D~ value of mlCNBD (499 ± 69 nM) ([@bib20]).

The fluorescence of GFP derivatives, in particular YFP and citrine, is pH sensitive ([@bib30]). Therefore, we measured the emission spectrum of mlCNBD-FRET (while exciting cerulean) at different pH values. The citrine emission peak at 529 nm increased at higher pH values and saturated at pH ≥ 7.5, whereas the cerulean emission at 475 nm was largely pH-insensitive ([Figure 2F,G](#fig2){ref-type="fig"}). The K~D~ for cAMP binding was only modestly affected by changes in pH (pH 6: 101 ± 5 nM, pH 7: 98 ± 21 nM; pH 7.5: 66 ± 15 nM, pH 8: 50 ± 13; n = 3), indicating that the cAMP affinity might increase upon alkalization. Of note, it has been reported for other CNBDs that the cAMP affinity depends on the pH ([@bib29]; [@bib42]).

We also measured FRET using Fluorescence Lifetime Spectroscopy (FLS). The fluorescence lifetime of the donor decreases during FRET. Because cAMP binding to mlCNBD-FRET reduces FRET, the cerulean lifetime should increase upon binding. The decay of cerulean fluorescence alone was fitted with a bi-exponential function (weighted mean of the two lifetime constants τ~wm~ = 2.52 ± 0.09 ns,n = 12). In mlCNBD-FRET, the cerulean lifetime decreased (τ~wm~ = 2.38 ± 0.04 ns, n = 11). Saturating cAMP (5 μM) decreased FRET and, thereby, the cerulean lifetime increased (τ~wm~ = 2.44 ± 0.03 ns, n = 5). In summary, the mlCNBD-FRET sensor is suitable for both intensity- and lifetime-based approaches.

Response kinetics of the FRET sensor {#s2-2}
------------------------------------

The response time of the sensor to rapid changes in cAMP was determined using the stopped-flow technique. Different cAMP concentrations were mixed with purified mlCNBD-FRET protein. From the time course of the FRET response, we determined the time constant for the changes in fluorescence by numerically fitting a simple one-step model to the data ([Figure 2H](#fig2){ref-type="fig"}, see materials & methods). According to this model, the overall *on* and *off* rates of ligand binding and changes in FRET are 2.5 ± 0.6 \* 10^7^ M^-1 ^s^-1^ and 9.3 ± 6.7 s^-1^ (n = 3). The *off* rate is rate-limiting, resulting in a time constant of about 100 ms. Thus, mlCNBD-FRET allows measuring cAMP changes on a 100 millisecond time scale.

Characterization of mlCNBD-FRET in mammalian cell lines {#s2-3}
-------------------------------------------------------

We tested mlCNBD-FRET in a cellular environment using HEK293 cells. Western blotting confirmed the expression of mlCNBD-FRET ([Figure 3A](#fig3){ref-type="fig"}); the sensor was mainly localized to the cytosol, but a fraction also resided in the nucleus ([Figure 3B](#fig3){ref-type="fig"}).

To determine the cAMP-binding characteristics, we calibrated mlCNBD-FRET by bathing digitonin-permeabilized HEK293 cells in defined cAMP concentrations. The K~D~ for cAMP binding was 73 ± 20 nM (n = 11, [Figure 3C](#fig3){ref-type="fig"}), which is similar to that of the purified mlCNBD-FRET (66 ± 15 nM, [Figure 2D](#fig2){ref-type="fig"}). Using the K~D~ value and the cAMP null-point calibration, we determined a basal free cAMP concentration of 35 ± 1 nM (n = 3, [Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}).10.7554/eLife.14052.005Figure 3.Characterization of mlCNBD-FRET in HEK293 cells.(**A**). Representative Western blot using total protein lysates from mlCNBD-FRET and mlCNBD-FRET-R307Q-expressing cells, stained with an anti-His and an anti-GFP antibody. Calnexin (Cal) has been used as a loading control. (**B**) Immunocytochemistry. HEK293 cells expressing mlCNBD-FRET (cerulean: blue, citrine: green) have been labeled with an anti-GFP antibody and a fluorescent secondary antibody (red). Scale bar 25 µm. (**C**) Ligand binding of cAMP to mlCNBD-FRET in HEK293 cells determined by fluorescence spectroscopy. Representative experiment showing an increase of the baseline-corrected cerulean/citrine emission ratio ΔF of mlCNBD-FRET (430 nm excitation) at different cAMP concentrations. Cells have been permeabilized with 20 μM digitonin before addition of cAMP. Data have been fitted using a single binding-site model (red line) ([@bib20]). (**D**) Changes in FRET in HEK293 cells expressing mlCNBD-FRET after stimulation with 40 μM NKH477/500 μM IBMX. FRET has been measured by fluorescence microscopy. Representative traces of raw data are shown above. HEK293 cells expressing mlCNBD-FRET-R307Q (grey) have been used as a control. Data are presented as mean ± S.D. (mlCNBD-FRET: n = 31; mlCNBD-FRETR307Q: n = 3). (**E**) Changes in FRET in HEK293 cells expressing mlCNBD-FRET after stimulation with 2 μM isoproterenol. Representative traces for the raw data are shown above. Data are presented as mean ± S.D.; n = 9. (**F**) Changes in FRET in HEK293 cells expressing mlCNBD-FRET after stimulation with 3 mM SNP. Representative traces for the raw data are shown above. Data are presented as mean ± S.D.; n = 36. (**G**) Changes in FRET in HEK293 cells expressing mlCNBD-FRET (black) or mlCNBD-FRET-R307Q (grey) after stimulation with 40 μM NKH477. After reaching a steady-state, cells have been permeabilized using 1 μM digitonin. FRET has been measured using spectrofluorometer. Data are presented as mean ± S.D.; n = 3. (**H**) Changes in cerulean fluorescence lifetime using FLIM. HEK293 cells expressing mlCNBD-FRET were imaged under basal conditions, after addition of 20 μM digitonin, and the following addition of 5 μM cAMP. The cerulean fluorescence decay was recorded and fitted with a bi-exponential decay to calculate the lifetime. Data are presented as mean ± S.D. Representative images are shown using a look-up table ranging from 2.1 ns (blue) to 2.7 ns (red). (**I**) Mean values of the two lifetimes averaged over different regions of interest in part (**H**); n = 8 for each condition.**DOI:** [http://dx.doi.org/10.7554/eLife.14052.005](10.7554/eLife.14052.005)10.7554/eLife.14052.006Figure 3---figure supplement 1.Characterisation of mlCNBD-FRET in HEK293 cells.(**A**) Calibration of mlCNBD-FRET in HEK293 cells. FRET was measured in a cuvette in a spectrofluorometer under basal conditions (ES), after permeabilization with 20 μM digitonin, and the following addition of increasing cAMP concentrations (in nM). According to the null-point calibration method, the difference in FRET ratio of the treated samples to the basal condition was determined and used to determine the basal cAMP concentration. (**B**) Changes in FRET in HEK293 cells expressing mlCNBD-FRET after stimulation with 40 μM NKH477/500 μM IBMX (black). FRET has been measured using spectrofluorometer. Data are presented as mean ± S.D. DMSO (0.13%, red) has been used as a control; n = 3 for each condition. (**C**) Similar to part (**B**) after stimulation with 2 μM isoproterenol (black). (**D**) Similar to part (**B**) for stimulation with 3 mM SNP (black). (**E**) Change in the cerulean fluorescence lifetime measured using Fluorescence Lifetime Spectroscopy (FLS). Cells have been permeabilized with 20 μM digitonin followed by addition of cAMP. The cerulean fluorescence decay was recorded and fitted with a bi-exponential decay to calculate the lifetime. The mean of the two lifetimes was calculated and averaged over n = 3 experiments. (**F**) Changes in FRET in HEK293 cells expressing mlCNBD-FRET after stimulation with different concentrations of NKH477. The FRET ratio has been calculated when reaching a maximum and normalized to the baseline ratio. Data is shown as mean ± S.D.; n = 4. (**G**) Changes in FRET in HEK293 cells expressing mlCNBD-FRET after alternatingly stimulating with 500 nM isoproterenol (black) followed by a wash-out with ES. As a control, cells were stimulated with buffer only (red). Data is shown as mean ± S.D.; n = 3.**DOI:** [http://dx.doi.org/10.7554/eLife.14052.006](10.7554/eLife.14052.006)

Next, we studied the cAMP dynamics of mlCNBD-FRET-expressing HEK293 cells by stimulation with a mixture of 40 µM NKH477 and 500 µM IBMX: NKH477 activates transmembrane adenylate cyclases that synthesize cAMP (tmAC) ([@bib35]), whereas IBMX inhibits phosphodiesterases (PDEs) that hydrolyze cAMP ([@bib70]). NKH477/IBMX treatment increased △F, reflecting an increase of cAMP levels ([Figure 3D](#fig3){ref-type="fig"}). Of note, the changes in citrine and cerulean emission are of opposite sign but similar time course, demonstrating that the changes in fluorescence were owing to FRET and not to fluorescence artefacts. The FRET change commenced within a few seconds after stimulation and reached a steady-state after 10 min (ratio increase: 43 ± 4%, n = 31, [Figure 3D](#fig3){ref-type="fig"}). HEK293 control cells expressing the cAMP-insensitive mlCNBD-FRET-R307Q mutant did not respond (n = 3, [Figure 3D](#fig3){ref-type="fig"}). We also studied whether the mlCNBD-FRET sensor reports a cAMP increase mediated by G protein-coupled receptors: stimulation with 20 µM isoproterenol, an agonist of beta-adrenergic receptors, rapidly changed △F by 47 ± 3% (n = 9, [Figure 3E](#fig3){ref-type="fig"}). mlCNBD-FRET also reports changes in cGMP; stimulation with 3 mM SNP, which releases nitric oxide (NO) that activates soluble guanylyl cyclases ([@bib23]), changed △F by 25 ± 5% (n = 36, [Figure 3F](#fig3){ref-type="fig"}). Similar results were obtained using cell populations: NKH477/IBMX and isoproterenol treatment both evoked a larger change than SNP (n = 3, [Figure 3---figure supplement 1B--D](#fig3s1){ref-type="fig"}). The twofold difference in the maximal changes evoked by drugs that stimulate cAMP- or cGMP-synthesis factors seems small, considering that the respective K~D~ values differ by 10fold. Probably, at rest, the sensor is partially occupied by cAMP and stimulation with NKH477/IBMX or isoproterenol saturates the response. To test the sensor with submaximal agonist concentrations, we stimulated cells with increasing concentrations of NKH477 and analyzed the dose-response relationship ([Figure 3---figure supplement 1F](#fig3s1){ref-type="fig"}). The EC~50~ for NKH477 was 3.6 ± 0.6 μM (n = 4).

Moreover, we analyzed whether mlCNBD-FRET also reliably reports a decrease of cAMP levels. HEK293 cell populations were pre-stimulated with NKH477 until steady-state before permeabilizing with 1 μM digitonin to release cAMP ([Figure 3G](#fig3){ref-type="fig"}). In turn, the FRET ratio decreased ([Figure 3G](#fig3){ref-type="fig"}), demonstrating that mlCNBD-FRET registers both, an increase and decrease of the intracellular cAMP concentration. To rule out any unspecific effects during permeabilization, we used mlCNBD-FRET-R307Q-expressing cells as a control. Here, the FRET ratio remained constant after NKH477 stimulation; only a small decrease occurred upon addition of digitonin ([Figure 3G](#fig3){ref-type="fig"}).

Similarly, we tested the reversibility of the sensor by alternatingly stimulating with isoproterenol followed by a wash-out step. Stimulation with 500 nM isoproterenol increased the FRET ratio ([Figure 3---figure supplement 1G](#fig3s1){ref-type="fig"}). When reaching a maximum, the stimulus was removed and in turn, the FRET ratio decreased. Afterwards, a second stimulus of 500 nM isoproterenol was applied, which resulted in a similar increase as observed for the first stimulus ([Figure 3---figure supplement 1G](#fig3s1){ref-type="fig"}).

Finally, we also tested the performance of mlCNBD-FRET in a cellular environment by two different lifetime-based techniques. First, using FLS, we calibrated the sensor with defined cAMP concentrations in permeabilized, mlCNBD-FRET-expressing HEK293 cells. The cerulean lifetime increased after cAMP addition ([Figure 3---figure supplement 1E](#fig3s1){ref-type="fig"}). The K~D~ for cAMP derived from the dose-lifetime relationship was 99.0 ± 10.1 nM (n = 3), which is similar to the K~D~ derived from fluorescence intensity-based FRET (73 ± 20 nM). Furthermore, the basal free cAMP concentration in HEK293 cells, calculated from lifetime and intensity-based measurements, was similar (48.7 ± 11.0 nM vs. 35 ± 1 nM, respectively, n = 3). To evoke cAMP changes in intact cells, cells were treated with NKH477/IBMX, which also prolonged the cerulean lifetime compared to controls (τ~wm~ = 1.88 ± 0.04 ns vs. τ~wm~ = 1.98 ± 0.03 ns, n = 9).

Second, we used FRET Fluorescence Lifetime Imaging (FLIM). In mlCNBD-FRET-expressing HEK293 cells, the cerulean lifetime decreased as a result of FRET (τ~wm~ =2.44 ± 0.02 ns vs. τ~wm~ =3.28 ± 0.07 ns for cerulean only, n = 9). Upon addition of NKH477/IBMX, the cerulean lifetime increased when FRET decreased (τ~wm~ =2.50 ± 0.02 ns, n = 9). To explore the dynamic range, we first permeabilized cells to release intracellular cAMP, followed by addition of a saturating cAMP concentration (5 μM). The shift of lifetime upon changes in cAMP is illustrated in the color-coded FLIM images ([Figure 3H](#fig3){ref-type="fig"}). The cerulean lifetime decreased after digitonin treatment from τ~wm~ = 2.44 ± 0.02 ns to τ~wm~ =2.38 ± 0.04 ns (n = 8), reflecting a cAMP decrease. Upon addition of cAMP, the lifetime increased to τ~wm~ =2.47 ± 0.05 ns (n = 8, [Figure 3H,I](#fig3){ref-type="fig"}). In summary, mlCNBD-FRET is an exquisitely sensitive biosensor for measuring cAMP dynamics in the nanomolar range, preferably using fluorescence intensity techniques, but also using lifetime-based techniques.

Expression and analysis of mlCNBD-FRET in mouse sperm {#s2-4}
-----------------------------------------------------

To study cAMP dynamics in sperm flagella, we generated transgenic mice expressing mlCNBD-FRET under the control of the protamine 1 promoter (*Prm1*, [Figure 4A](#fig4){ref-type="fig"}). Transgenic mice were generated by pronuclear injection using standard procedures ([@bib38]). Genomic insertion of the transgene was confirmed by PCR ([Figure 4B](#fig4){ref-type="fig"}). The mlCNBD-FRET protein was exclusively expressed in sperm and was mainly targeted to the flagellum ([Figure 4C--E](#fig4){ref-type="fig"}). *Prm1*-mlCNBD-FRET males were fertile, demonstrating that mlCNBD-FRET does not impair sperm function ([Figure 4---source data 1](#SD1-data){ref-type="supplementary-material"}).10.7554/eLife.14052.007Figure 4.Generation of a *Prm1*-mlCNBD-FRET transgenic mouse line.(**A**) Scheme of the *Prm1*-mlCNBD-FRET targeting vector. Expression of hemagglutinin(HA)-tagged mlCNBD-FRET is driven by the Protamine 1 promoter (*Prm1*); arrows indicate the position of genotyping primers (\#1, 2). (**B**) Genotyping by PCR. In *Prm1*-mlCNBD-FRET mice, a 653 bp fragment is amplified (1). The targeting vector served as a positive control (+). (**C**) Western blot analysis of mlCNBD-FRET expression in lysates from different tissues from a transgenic male and a female. Lysates from HEK293 cells expressing mlCNBD-FRET served as positive control. Proteins have been labeled using an anti-GFP antibody. (**D**) Western blot analysis of mlCNBD-FRET expression in testis and sperm lysates from a wild-type and a transgenic male. Lysates from HEK cells expressing mlCNBD-FRET served as positive control. Proteins have been labeled using an anti-GFP antibody; tubulin has been used as a loading control. (**E**) Immunohistochemical analysis of mlCNBD-FRET expression in testis and sperm. Cryosections of mouse testis were probed with anti-HA antibody and fluorescent secondary antibody (purple); the fluorescence for cerulean (blue) or citrine (green) is also shown.**DOI:** [http://dx.doi.org/10.7554/eLife.14052.007](10.7554/eLife.14052.007)10.7554/eLife.14052.008Figure 4---source data 1.Fertility parameters of mlCNBD-FRET transgenic males.For matings, heterozygous males have been crossed with wild-type females. All data are represented as mean ± S.D., n numbers are indicated.**DOI:** [http://dx.doi.org/10.7554/eLife.14052.008](10.7554/eLife.14052.008)

To calibrate mlCNBD-FRET in sperm, we followed a similar strategy as used for HEK293 cells. Titration of digitonin-treated sperm with cAMP decreased FRET, thereby increasing the FRET ratio ([Figure 5A](#fig5){ref-type="fig"}). The mean K~D~ value derived from the dose-response relation was 103 ± 31 nM (n = 7, [Figure 5A](#fig5){ref-type="fig"}). We also measured by FLS the cerulean lifetime of mlCNBD-FRET sperm. At rest, the cerulean lifetime was τ~wm~ = 2.0 ± 0.1 ns (n = 4); addition of cAMP to digitonin-treated sperm prolonged the cerulean lifetime. At saturating cAMP concentrations (6 μM), the lifetime was τ~wm~ = 2.3 ± 0.03 ns (n = 3). The mlCNBD-FRET characteristics for cAMP binding in the different systems are summarized in a table ([Figure 5---source data 1](#SD2-data){ref-type="supplementary-material"}). For comparison, we have also included a summary of cAMP biosensors and their characteristics ([Figure 5---source data 2](#SD3-data){ref-type="supplementary-material"}). In summary, the sensor allows measuring changes in cAMP levels in sperm using fluorescence intensity and lifetime-based approaches.10.7554/eLife.14052.009Figure 5.Characterization of cAMP dynamics in sperm.(**A**) Ligand binding of cAMP to mlCNBD-FRET in mouse sperm determined by fluorescence spectroscopy. Representative experiment showing an increase in the baseline-corrected cerulean/citrine emission ratio (△F) of mlCNBD-FRET (430 nm excitation) after cAMP binding. Cells have been permeabilized with digitonin before addition of cAMP. Data have been fitted using a single binding-site model (red line) ([@bib20]); n = 7. (**B**) Fluorescence spectra of mlCNBD-FRET at 430 nm excitation before (black) and after stimulation for 5 min with 25 mM bicarbonate (red). (**C**) Changes in FRET after stimulation of a mlCNBD-FRET sperm with 25 mM bicarbonate. Sperm have been kept in 2 mM Ca^2+^ buffer. FRET has been measured using a spectrofluorometer. Data is shown as mean ± S.D.; n = 3. (**D**) Total cAMP content. Sperm have been stimulated with 25 mM bicarbonate for 1 or 10 min and the total cAMP content has been determined using an immunoassay. The p values according to Students t-test are indicated. Data are shown as mean ± S.D.; n = 4.**DOI:** [http://dx.doi.org/10.7554/eLife.14052.009](10.7554/eLife.14052.009)10.7554/eLife.14052.010Figure 5---source data 1.Characteristics of mlCNBD-FRET.Binding affinities and the cerulean lifetime are shown as mean ± S.D.; n numbers are indicated.**DOI:** [http://dx.doi.org/10.7554/eLife.14052.010](10.7554/eLife.14052.010)10.7554/eLife.14052.011Figure 5---source data 2.Characteristics of other cAMP biosensors.**DOI:** [http://dx.doi.org/10.7554/eLife.14052.011](10.7554/eLife.14052.011)10.7554/eLife.14052.012Figure 5---figure supplement 1.Characterisation of mlCNBD-FRET in mouse sperm.(**A**) Changes in pH~i~ in wild-type sperm. Wild-type sperm have been loaded with BCECF and changes in pH~i~, after stimulation with 10 mM NH~4~Cl or 25 mM bicarbonate, have been measured using the stopped-flow technique. Data are shown as mean ± 95% CI (confidence interval); n = 4. (**B**) Changes in FRET ratio of mlCNBD-FRET sperm after stimulation with 25 mM NH~4~Cl. Data is shown as mean ± S.D.; n = 8.**DOI:** [http://dx.doi.org/10.7554/eLife.14052.012](10.7554/eLife.14052.012)

Dynamics of free and total cAMP in sperm {#s2-5}
----------------------------------------

Changes in cAMP levels in sperm have previously been inferred from total cAMP concentrations measured with immunoassays. However, total cyclic nucleotide concentrations in cells are several orders of magnitude larger than free concentrations. Moreover, large volume ratios between the soma and small compartments like flagella might obscure the extent and time course of changes in cAMP. Therefore, we compared the dynamics of total and free cAMP in sperm upon stimulation with bicarbonate. Bicarbonate (25 mM) increased the FRET ratio, reflecting an increase of the free cAMP concentration ([Figure 5B](#fig5){ref-type="fig"}). cAMP commenced to rise within seconds, reached a steady-state after about 5 min, and persisted during bicarbonate stimulation ([Figure 5C](#fig5){ref-type="fig"}). In contrast, total cAMP levels, after a rapid rise (1 min), declined again to basal levels within 10 min ([Figure 5D](#fig5){ref-type="fig"}). Previous studies also reported a transient increase of cAMP during bicarbonate stimulation, although the extent and speed of recovery varied among species ([@bib3]; [@bib6]). In essence, the changes in total cAMP concentration unsatisfactorily reflect the changes in free cAMP levels in mouse sperm.

Of note, we tested whether the bicarbonate-induced increase in FRET ratio reflects a change in cAMP levels and not a change in the intracellular pH~i~. Wild-type sperm were loaded with the fluorescent pH indicator BCECF and changes in pH~i~ were measured after stimulation with 25 mM bicarbonate or 10 mM NH~4~Cl as a control. Stimulation with NH~4~Cl, evoked a pronounced alkalization and, in turn, decreased the FRET ratio ([Figure 5---figure supplement 1A,B](#fig5s1){ref-type="fig"}). The kinetics of both changes were similar, indicating that the change in FRET is evoked by the change in pH~i~. In contrast, stimulation with NaHCO~3~ did not dramatically change pH~i~ ([Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}). These results support the notion that the changes in FRET evoked by NaHCO~3~ reflect changes in cAMP rather than pH~i~.

Expression of mlCNBD-FRET also allows spatially resolving cAMP dynamics in sperm. The mlCNBD-FRET biosensor is predominantly expressed in the flagellum ([Figure 4E](#fig4){ref-type="fig"}). Although the major if not only cAMP source is SACY ([@bib6]; [@bib26]; [@bib33]), a debate continues about the presence and function of transmembrane adenylate cyclases (tmACs) ([@bib8]; [@bib77]; [@bib82]), for a comprehensive discussion see ([@bib6]). To gain more insight, a spatio-temporal analysis of tmAC- and SACY-dependent changes in cAMP is required. Stimulation by NKH477 and bicarbonate discriminates between tmACs and SACY activity, respectively. Thus, we measured cAMP dynamics in the freely beating flagellum of mlCNBD-FRET sperm upon perfusion with 40 μM NKH477 or 25 mM bicarbonate. mlCNBD-FRET is equally distributed along the flagellum, which allows distinguishing between the cAMP dynamics in the midpiece and principal piece ([Figure 6A](#fig6){ref-type="fig"}; blue and green region, respectively). Invariably, no cAMP change in either the midpiece or principal piece was detected after perfusion with NKH477 (0 ± 3%, n = 3, [Figure 6B](#fig6){ref-type="fig"}). Thus, our results rule out the presence of tmACs in the sperm flagellum. However, perfusion with bicarbonate increased cAMP levels in both, midpiece (26 ± 3% ) and principal piece (22 ± 10% ) (n = 7, [Figure 6C](#fig6){ref-type="fig"}). To compare the response kinetics in the two compartments, individual traces were fitted using a logistic regression (Origin 9.0) and average data were plotted ([Figure 6D](#fig6){ref-type="fig"}). The kinetics of the cAMP increase by bicarbonate was faster in the principal piece than in the midpiece, indicating that cAMP dynamics in these two compartments is differently regulated.10.7554/eLife.14052.013Figure 6.Spatio-temporal cAMP dynamics in the sperm flagellum.(**A**) cAMP dynamics was analyzed in a region 20 µm in length in the midpiece (blue) and principal piece (green) of freely beating sperm. The cytoplasmic droplet is indicated with an arrow. (**B**) Changes in FRET after stimulation with 40 μM NKH477. The perfusion with NKH477 is indicated with a grey box. Data for a representative cell are shown as mean ± S.D. in the midpiece (blue) and principal piece (green). (**C**) Changes in FRET after stimulation with 25 mM bicarbonate. The perfusion with bicarbonate is indicated with a blue box. Individual traces have been fitted using logistic regression (Origin 9) (red line). (**D**) Average of the fitted data presented in (**C**). The blue and green line represent the mean value for the midpiece and principal piece, respectively (n = 7). The blue and green areas represent the corresponding S.D.**DOI:** [http://dx.doi.org/10.7554/eLife.14052.013](10.7554/eLife.14052.013)

Regulation of cAMP dynamics by Ca^2+^ {#s2-6}
-------------------------------------

SACY activity is controlled by bicarbonate and Ca^2+^ ([@bib12]; [@bib14]; [@bib39]; [@bib49]; [@bib81]). Ca^2+^ enhances the *in vitro* activity of native or heterologously expressed SACY in a dose-dependent manner ([@bib39]). In intact sperm, several read-outs including total cAMP content, flagellar beat frequency, stimulation of PKA activity, and increase of tyrosine phosphorylation have been used to assess SACY activity ([@bib12]; [@bib58]; [@bib79]; [@bib81]). For example, stimulation of sperm with bicarbonate in so-called nominally Ca^2+^-free buffers, which contain an undefined free Ca^2+^ concentration \[Ca^2+^\]~o~ in the low micromolar range ([@bib51]), does not increase the flagellar beat frequency ([@bib12]; [@bib81]). Recently, it has been proposed that Ca^2+^ regulates cAMP signaling in a biphasic manner ([@bib58]), i.e. cAMP signaling seems to be stimulated at extremely low \[Ca^2+^\]~o~. Although \[Ca^2+^\]~i~ is not as well defined as \[Ca^2+^\] in cell-free assays ([@bib39]), it is reasonable to assume that \[Ca^2+^\]~o~ affects \[Ca^2+^\]~i~ accordingly. Given the limitations of indirect read-outs of free cAMP concentrations, we studied the Ca^2+^ regulation of SACY using mlCNBD-FRET.

We followed the changes in cAMP upon stimulation with 25 mM bicarbonate in buffer with defined Ca^2+^ concentrations of 10 μM \[Ca^2+^\]~o~ (low) and 2 mM \[Ca^2+^\]~o~ (normal) under otherwise identical conditions ([Figure 7A](#fig7){ref-type="fig"}). In agreement with indirect read-outs, bicarbonate did not change the cAMP concentration at 10 μM \[Ca^2+^\]~o~, whereas readjusting \[Ca^2+^\]~o~ to 2 mM rapidly elevated cAMP levels ([Figure 7A](#fig7){ref-type="fig"}). These results demonstrate that stimulation of SACY activity by bicarbonate requires Ca^2+^ and that the regulation by Ca^2+^ is fully and rapidly reversible.10.7554/eLife.14052.014Figure 7.Ca^2+^ regulation of cAMP dynamics in sperm.(**A**) Changes in FRET after stimulation of mlCNBD-FRET sperm with 25 mM bicarbonate. Sperm have been either kept in 2 mM (black) or 10 μM (grey) Ca^2+^ buffer. FRET has been measured using a spectrofluorometer; n = 3 for each condition. (**B**) Changes in FRET after stimulation of a mlCNBD-FRET sperm kept 10 μM Ca^2+^ buffer with 25 mM bicarbonate, followed by addition of 2 mM Ca^2+^ (final concentration); n = 3. (**C**) Changes in FRET of mlCNBD-FRET sperm kept in 2 mM Ca^2+^ buffer after the addition of 2 mM BAPTA (final: 20 μM Ca^2+^, black), kept in 10 μM Ca^2+^ buffer after the addition of 1 mM BAPTA (final: 2.2 nM Ca^2+^, red), or kept in 2 mM Ca^2+^ buffer after the addition of 3 mM BAPTA (final: 443 nM Ca^2+^, blue). Arrow indicates the addition of Ca^2+^or BAPTA, the dotted line indicates the baseline; n = 4 for each condition. (**D**) Changes in FRET of mlCNBD-FRET sperm kept in 10 μM Ca^2+^/1 mM BAPTA after addition of bicarbonate followed by 3 mM Ca^2+^ (final: 2 mM Ca^2+^). Data is shown as mean ± S.D; n = 4. (**E**) Changes in pH~i~ of wild-type sperm kept in 2 mM Ca^2+^ buffer after addition of 25 mM NH~4~Cl. Data is shown as mean ± S.D.; n = 3. (**F**) Changes in pH~i~ of wild-type sperm kept in 2 mM Ca^2+^ buffer after addition of 3 mM BAPTA (final: 443 nM Ca^2+^, black) or buffer (red) as a control. Data represents the mean of n = 3.**DOI:** [http://dx.doi.org/10.7554/eLife.14052.014](10.7554/eLife.14052.014)

Next, we studied basal SACY activity (in the absence of bicarbonate) when Ca^2+^ was stepped to various lower \[Ca^2+^\]~o~ ([Figure 7C,D](#fig7){ref-type="fig"}). Surprisingly, stepping \[Ca^2+^\]~o~ from 2 mM to 20 μM moderately increased cAMP levels ([Figure 7C](#fig7){ref-type="fig"}). A similar increase was observed when \[Ca^2+^\]~o~ was decreased from 2 mM to 443 nM orfrom 10 μM to 2.2 nM ([Figure 7C](#fig7){ref-type="fig"}). Stimulation with bicarbonate at 2.2 nM \[Ca^2+^\]~o~ did not further enhance cAMP levels; however, when \[Ca^2+^\]~o~ was re-adjusted to 2 mM, bicarbonate was able to stimulate SACY activity ([Figure 7D](#fig7){ref-type="fig"}).

As a control, we analyzed whether changing \[Ca^2+^\]~o~ has an effect on the intracellular pH~i~. Thus, we measured changes in pH using BCECF in wild-type mouse sperm after changing \[Ca^2+^\]~o~. Reducing \[Ca^2+^\]~o~ to 443 nM by addition of 3 mM BAPTA did not change pH~i~ ([Figure 7F](#fig7){ref-type="fig"}). We conclude that the △\[Ca^2+^\]~o~-evoked changes in FRET reflect changes in cAMP rather than in pH~i~.

In summary, these results demonstrate that stimulation of SACY by bicarbonate requires Ca^2+^ and that Ca^2+^ alone, in the absence of bicarbonate, inhibits rather than activates SACY.

Targeting mlCNBD-FRET to primary cilia {#s2-7}
--------------------------------------

Although components of cAMP signaling are also localized to primary cilia ([@bib4]; [@bib5]; [@bib37]), the physiological function of cAMP in primary cilia is ill defined. The analysis has been hampered by the lack of suitable tools to manipulate and analyze cAMP signaling in such a tiny cellular compartment. We set out to target mlCNBD-FRET to primary cilia. Protein import into the cilium is tightly regulated by the intraflagellar transport machinery ([@bib69]). For targeting to cilia, we fused the mlCNBD-FRET sensor to the C-terminus of the ciliary somatostatin receptor 3 (SSTR3) ([@bib37]); as control, we fused a green-fluorescent protein (eGFP) to SSTR3 ([Figure 8A](#fig8){ref-type="fig"}). Both constructs were expressed in IMCD3 cells, which carry primary cilia. In fact, both constructs were targeted to primary cilia ([Figure 8B,C](#fig8){ref-type="fig"}). To test whether fusion of mlCNBD-FRET to SSTR3 affects the sensor properties, SSTR3-mlCNBD-FRET was expressed in HEK293 cells. Compared to mlCNBD-FRET, SSTR3-mlCNBD-FRET was localized to intracellular membranes rather than uniformly distributed throughout cells ([Figure 3B vs. 8D](#fig3){ref-type="fig"}). Stimulation with isoproterenol (20 μM) increased the FRET ratio by approximately 25% compared to 40% for the non-tagged sensor (n = 9, [Figure 3E vs. 8E](#fig3){ref-type="fig"}). Thus, the SSTR3-mlCNBD-FRET fusion protein allows measuring cAMP dynamics. The functionality of mlCNBD-FRET in primary cilia of IMCD-3 cells was tested by acceptor photobleaching experiments. Upon bleaching, the cerulean emission increased (n = 11, 43 ± 21%), demonstrating that the SSTR3-fusion protein undergoes FRET ([Figure 8F](#fig8){ref-type="fig"}). In summary, mlCNBD-FRET is a versatile tool that can be used to measure cAMP dynamics with nanomolar sensitivity in solution, in different cell types, and small cellular compartments like the cilium or flagellum.10.7554/eLife.14052.015Figure 8.Targeting mlCNBD-FRET to primary cilia.(**A**) Strategy to target a protein to cilia. The somatostatin receptor 3 (SSTR3) has been fused to green fluorescent protein (eGFP) or mlCNBD-FRET. (**B**) Expression of eGFP in primary cilia of IMCD3 cells. An anti-acetylated tubulin antibody has been used as a marker for primary cilia. DNA has been labeled using DAPI. Scale bar is indicated. (**C**) Expression of mlCNBD-FRET in primary cilia of IMCD3 cells. Citrine fluorescence indicates the expression of mlCNBD-FRET. An anti-acetylated tubulin antibody has been used as a marker for primary cilia. DNA has been labeled using DAPI. Scale bar is indicated. (**D**) Representative image for HEK293 cells expressing SSTR3-mlCNBD-FRET. (**E**) Changes in FRET in HEK293 cells expressing SSTR3-mlCNBD-FRET (see **D**) after stimulation with 20 μM isoproterenol (black) or buffer only (grey). FRET has been measured using fluorescence microscopy. Data are presented as mean ± S.D.; n = 9 for each condition. (**F**) Acceptor photobleaching. The citrine (acceptor) fluorescence of mlCNBD-FRET in IMCD3 cells was bleached for 2 min with a mercury lamp using a 510/20 nm filter. A representative image is shown. The cerulean emission was recorded before and after acceptor photobleaching. Relative fluorescence intensities are color-coded from low (blue) to high (red). Scale bars are indicated.**DOI:** [http://dx.doi.org/10.7554/eLife.14052.015](10.7554/eLife.14052.015)

Discussion {#s3}
==========

We developed a novel FRET-based biosensor to quantitatively measure cAMP dynamics. The sensor is quite versatile. First, unlike any other cAMP biosensor, the purified mlCNBD-FRET protein can be used in solution. Remarkably, the properties in solution and inside cells are by and large similar. Second, mlCNBD-FRET can be selectively targeted to subcellular compartments like primary cilia or sperm flagella to directly measure cAMP dynamics. Third, the sensor exhibits a significantly improved cAMP sensitivity compared to other single-protein biosensors, e.g. Epac-based FRET sensors. Thereby, it extends the range of accessible cAMP concentrations to the low nanomolar range. In fact, other cAMP sensors are unable to quantify resting cAMP levels in some cells ([@bib11]). Finally, the sensor is compatible with fluorescence intensity and lifetime-based approaches. These favorable characteristics prompted us to revisit a lingering debate about cAMP signaling in sperm.

One issue concerns the presence, localization, and function of tmACs in sperm ([@bib6]; [@bib8]; [@bib77]; [@bib82]); for a detailed account of pros and cons see ([@bib6]). SACY is the major source for cAMP in sperm and total cAMP levels in SACY^-/-^ sperm are below the detection limit ([@bib86]). Members of the tmAC family and the corresponding G proteins reportedly localize to the sperm head, i.e. they are spatially segregated from SACY and PKA in the flagellum ([@bib82]). Our result that bicarbonate, but not NKH477, increases flagellar cAMP levels strengthens the notion that SACY represents the only cAMP source in the flagellum. Furthermore, considering that the head volume is much larger than that of the flagellum, our results also argue that the flagellum either is sealed up and that cAMP in the head does not propagate to the flagellum, or that NKH477-sensitive tmACs are absent altogether. A physical barrier that restricts diffusion of cAMP between midpiece and head is unlikely to exist, because Ca^2+^ entering the flagellum via CatSper channels propagates to the head ([@bib72]; [@bib85]). However, PDEs might serve as gatekeepers that prevent rapid cAMP exchange between head and flagellum.

Another conundrum concerns the relationship between cAMP signaling and tyrosine phosphorylation during capacitation. An important requisite for capacitation *in vitro* is bicarbonate and the ensuing rise of cAMP followed by PKA activation. PKA activity must be maintained for at least 30 min to initiate tyrosine phosphorylation ([@bib55]), which requires 90 min to complete. However, in mice, total cAMP levels return to basal values within 10 min ([Figure 5D](#fig5){ref-type="fig"}). This begs the question how PKA activity is sustained when cAMP levels recover during bicarbonate stimulation. We resolve this conundrum in mouse sperm by showing that the free cAMP concentration stays up during measurements ([Figure 5D](#fig5){ref-type="fig"}). Thus, total cAMP levels do not properly reflect free cAMP concentrations in live cells. This might be due to compartmentalization of cAMP signaling in sperm, similar to what has been shown for cardiomyocytes ([@bib88]), or due to buffering by cAMP-binding proteins. A case in point is the rod photoreceptor ([@bib87]). The free cGMP concentration in the dark is approximately 1 μM, whereas most of the total cGMP content (50 μM) is bound to high-affinity sites of PDEs ([@bib18]; [@bib19]). Light stimulation activates PDE, cGMP levels drop, and cyclic nucleotide-gated ion channels close, giving rise to a hyperpolarizing light response. Notably, a drop of the total cGMP concentration (maximally 50% ) requires light intensities that are orders of magnitude larger than those that saturate the light response ([@bib18]; [@bib19]). Likewise, the total cGMP concentration in sea urchin sperm is a few µM, whereas, at rest, the free cGMP must be ≤3 nM ([@bib10]; [@bib43]). The Ca^2+^ response in sea urchin sperm saturates at ≤20 pM of the chemoattractant, whereas approximately 5 nM chemoattractant are required to detect a noticeable rise of total cGMP concentration ([@bib43]).

A third issue concerns the regulation of SACY by Ca^2+^. SACY activity is stimulated by bicarbonate in buffer containing 2 mM Ca^2+^, but not in low micromolar Ca^2+^ buffer ([Figure 7A](#fig7){ref-type="fig"}) ([@bib12]; [@bib58]; [@bib81]). Recent findings suggest that Ca^2+^ has a biphasic role in the regulation of cAMP signaling ([@bib58]): at micromolar Ca^2+^-conditions, bicarbonate does not stimulate PKA activity or increase tyrosine phosphorylation; however, chelating \[Ca^2+^\]~o~ using EGTA in the presence of bicarbonate relieves the inhibition, stimulating PKA activity, and increasing tyrosine phosphorylation. Similarly, in CatSper1^-/-^ sperm, \[Ca^2+^\]~i~ is lower than in wild-type sperm ([@bib66]), yet tyrosine phosphorylation in the presence of bicarbonate is enhanced ([@bib16]). One interpretation of these seemingly puzzling results suggests that bicarbonate can stimulate SACY at normal and very low \[Ca^2+^\]~i~, but not at intermediate Ca^2+^ levels ([@bib58]). However, such a biphasic control by Ca^2+^ has not been observed *in vitro*. Instead, the activity of isolated SACY protein upon bicarbonate stimulation is steadily enhanced by Ca^2+^ in a dose-dependent manner ([@bib39]). Alternatively, Ca^2+^ might control cellular signaling downstream of cAMP. Here, we show that cAMP levels do not significantly change during bicarbonate stimulation at very low Ca^2+^ concentrations (2 nM); thus, a bicarbonate-dependent cAMP increase is not underlying the stimulation of PKA activity and tyrosine phosphorylation under these conditions. However, under conditions that are expected to significantly lower \[Ca^2+^\]~i~, basal SACY activity is stimulated, indicating that SACY activity is controlled by a Ca^2+^-dependent negative feedback that operates in intact sperm, but is absent on the isolated or heterologously expressed protein. Regulation of SACY activity via another negative feedback has been described before ([@bib9]; [@bib62]). In sperm lacking the catalytical PKA subunit Cα2, both basal and bicarbonate-stimulated cAMP levels are higher than in wild-type sperm ([@bib9]; [@bib62]), suggesting that PKA-dependent phosphorylation indirectly or directly down-regulates SACY activity.

cAMP-signaling components are not uniformly distributed throughout sperm: PKA and SACY are exclusively localized to the flagellum ([@bib33]; [@bib62]; [@bib82]). However, even along the flagellum, cAMP signaling is compartmentalized; the cAMP dynamics stimulated by bicarbonate is different in the midpiece and the principal piece. We favor the idea that distribution and activity of PDEs is different in the midpiece and principal piece. PDE are targeted to distinct domains in sperm ([@bib2]; [@bib48]). Moreover, at least two PDE isoforms and splice variants, PDE4 (cAMP-specific) and PDE1 (Ca^2+^/calmodulin-dependent) are involved in the control of sperm motility and tyrosine phosphorylation ([@bib27]; [@bib46]; [@bib48]; [@bib79]). Using mlCNBD-FRET mice, it will now be possible to analyze cAMP dynamics in different subcellular compartments and unravel the mechanisms underlying the differential regulation of cAMP signaling.

Finally, primary cilia constitute a unique Ca^2+^ compartment that is functionally distinct from the cytoplasm of the cell body ([@bib22]; [@bib21]). Ca^2+^ channels (PKD-Like1/2) in the plasma membrane of primary cilia maintain a higher resting Ca^2+^ concentration compared to the cell body, despite steady Ca^2+^ efflux via the ciliary base ([@bib22]; [@bib21]). Considering that primary cilia also host cAMP-signaling components ([@bib41]), we hypothesize that cAMP signaling in primary cilia might also be functionally distinct from the cell body. The combination of sensitive genetically-encoded cAMP biosensors and light-driven actuators ([@bib40]) provides the high spatial and temporal resolution that is needed to unravel cAMP-signaling pathways in cilia and flagella.

Material and methods {#s4}
====================

Cloning of mlCNBD-FRET {#s4-1}
----------------------

The mlCNBD cDNA sequence (cyclic nucleotide binding-domain) of the cyclic nucleotide-gated K^+^ channel from *Mesorhizobium loti* (MAFF303099, mll3241) was amplified via PCR ([@bib20]). For expression in mammalian cell lines, citrine and cerulean were amplified by PCR and fused to the N- and C-terminus of the mlCNBD via *BamH*I/*Hind*III or *Xho*I/*Apa*I, respectively. The C-terminus of cerulean contained a histidine (His~10~) tag. The PCR product was cloned into a pcDNA3.1(+) vector (Invitrogen, Darmstadt, Germany) using *BamH*I and *Apa*I (pc3.1-mlCNBD-FRET). For expression in *E.coli*, citrine was amplified by PCR from pc3.1-mlCNBD-FRET and an *Nde*I site was added at the 5'end to allow in-frame cloning into the pET21a vector (Novagen, Darmstadt, Germany). The mlCNBD fused to cerulean containing a His~10~ tag was amplified by PCR from pc3.1-mlCNBD-FRET and an *EcoR*I site was added at the 3'end. PCR products were cloned into pET21a using *Nde*I/*EcoR*I (pET21a-mlCNBD-FRET). The mutation encoding R307Q was introduced using the QuikChange site-directed mutagenesis protocol (Agilent Technologies, Santa Clara, CA).

Protein purification {#s4-2}
--------------------

The mlCNBD-FRET protein was expressed in *E. coli* (BL21 DE3 pLysE). Bacteria were grown at 37°C until density reached an OD~600~ = 0.6. Then, expression of mlCNBD-FRET was induced using 0.6 mM IPTG. The cells were grown overnight at 20°C and harvested after 18 hr. The cells were lysed in lysis buffer (20 mM NaP, 500 mM NaCl, 10 mM DNAse, pH 7.4) using ultrasonification followed by centrifugation at 45,000 g, 20 min, and 4°C. The supernatant containing the mlCNBD-FRET protein was loaded onto a 1 ml HiTrap cobalt-IMAC column (GE) pre-equilibrated with the binding buffer (20 mM NaP, 500 mM NaCl, 10 mM imidazole, pH 7.4) in the Äkta HPLC system (GE Healthcare, Solingen, Germany). After loading, the column was washed with 5 column volumes of binding buffer. Bound cAMP was removed from the protein by incubation for 10 min with 1 ml 8-CPT-cGMP (5 mM) (Biolog, Bremen, Germany). This step was performed three times followed by a washing step with 10 ml binding buffer. The mlCNBD-FRET was then eluted using a linear gradient (0--100%) of elution buffer (20 mM Na~3~PO~4~, 500 mM NaCl, 500 mM imidazole, pH 7.4).

To enrich properly folded protein, gel-filtration chromatography of mlCNBD-FRET was carried out using a Superdex 200, Hi-Load 16/60 column (Amersham Biosciences/GE Healthcare), which allows separating proteins with molecular weight between 30 and 200 kDa. The mlCNBD-FRET protein has an apparent molecular weight of 70.9 kDa. The column was washed and equilibrated with 2 column volumes of the gel-filtration buffer (GF buffer, 10 mM K~2~HPO~4~, 100 mM KCl, pH 7.4). Subsequently, the sample was injected onto the column and protein elution was followed at 280 nm. The protein fractions corresponding to the monomer were collected. This sample was flash frozen in GF buffer containing 10% glycerol and stored at -80°C.

Determination of cyclic nucleotide content by HPLC {#s4-3}
--------------------------------------------------

The purified mlCNBD-FRET still contained cAMP ([@bib20]). The cAMP was removed by incubation with the low-affinity analog 8-CPT-cGMP ([@bib20]) followed by extensive washing. To determine the cAMP content, protein samples were denatured and analysed as described before ([@bib20]) using a Zorbax SB-C18 column (5 μm, 250 mm x 0.46 mm, Agilent, Waldbronn, Germany). The column was calibrated and the detection limit for cAMP was determined by injecting increasing amounts of cAMP prepared in GF buffer. A linear gradient was produced from solution A (5 mM KH~2~PO~4~, pH 5.0) and solution B (80% methanol) at a flow rate of 0.3 ml/min. The absorbance for cAMP was detected at 256 nm with a retention time of 6.3 min. The final cAMP content of mlCNBD-FRET was below the detection limit.

Ligand-binding assay {#s4-4}
--------------------

To determine the affinity of the purified mlCNBD-FRET, known protein concentrations (ε = 53,290 M^-1^cm^-1^, MW = 70.9 kDa, calculated by ProtParam tool) were mixed with increasing concentrations of cAMP (Sigma-Aldrich, Seelze, Germany). The fluorescence was observed in a spectrofluorometer (Quantamaster 40, PTI) with excitation at 430 nm (cerulean) and emission at 471 nm (cerulean) and 529 nm (citrine). Fluorescence spectra were recorded using 430 nm excitation. FRET was calculated from the ratio of the emission intensities for cerulean at 471 nm over citrine at 529 nm. The change in FRET △F was plotted versus the cAMP concentration and fitted with a substrate-depletion model ([@bib20]) to calculate the K~D~ value for cAMP.

To determine the effect of pH on the mlCNBD-FRET sensor, the protein was exposed to different pH solutions (pH 6--8). The buffer solutions consisted of 100 mM KCl/10 mM HEPES and the pH was adjusted using 1 M NaOH. The protein was kept in 100 mM KCl/10 mM HEPES pH 7.4. For measurements, the protein solution (50 μM stock) was mixed 1:1000 with the corresponding pH buffer and the final pH of the solution was controlled again using a pH meter. Fluorescence spectra were recorded in a spectrofluorometer (Quantamaster 40, PTI) with excitation at 430 nm. The binding affinity was determined as described for the ligand-binding assay.

Kinetic measurements using the stopped-flow technique {#s4-5}
-----------------------------------------------------

For time-resolved recordings of FRET changes, purified mlCNBD-FRET protein was mixed 1:1 with cAMP in GF buffer in a rapid-mixing device (SFM400, Bio-Logic) at a flow-rate of 9.5 ml/s. Cerulean was excited by the blue LED of a SpectraX Light Engine (Lumencor, Beaverton, OR) and the excitation light was passed through a 435/24 nm filter (Semrock Brightline, Rochester, NY) onto the μFC08 cuvette. The emission was collected through 485/15 nm (cerulean) and 535/15 nm filters (citrine, Semrock Brightline). Fluorescence emission was recorded by photomultiplier modules (9656--20; Hamamatsu Photonics, Herrsching, Germany). Data acquisition was performed at 200 Hz with a data acquisition pad (PCI-6221; National Instruments, Austin, TX) and the Bio-Kine software v. 4.49 (Bio-Logic). Numerical analysis was carried out with Dynafit (v 3.28.070, BioKin, Watertown, MA) using a simple binding scheme.$$E~ + ~L~\overset{K_{on}}{\underset{K_{off}}{\rightleftarrows}}~EL$$

E, L, EL refer to the concentrations of the receptor, ligand, and receptor-ligand complex, respectively. *k~on~* describes the *on* rate for ligand binding along with the associated conformational change resulting in a FRET signal, *k~off ~ *describes the *off* rate of ligand dissociation from the receptor and the associated return to its resting-state conformation.

Measuring cAMP dynamics in mammalian cell lines {#s4-6}
-----------------------------------------------

HEK293 cells (ATCC CRL-1573, authentication method: STR profiling, mycoplasma test negative) were electroporated with pc3.1-mlCNBD-FRET or pc3.1-mlCNBD-FRET-R307Q using the Neon 100 µl kit (Invitrogen, Darmstadt, Germany) and the MicroPorator (Digital Bio, Invitrogen) according to the manufacture's protocol (3x 1245 mV pulses with 10 ms pulse width). Cells were transferred into complete medium composed of DMEM plus GlutaMax (Life Technologies GmbH, Carlsbad, CA) and 10% fetal bovine serum (Biochrom, Berlin, Germany). For the selection of monoclonal HEK293 cells stably expressing mlCNBD-FRET, the antibiotic G418 (800 µg/ml, Invitrogen) was added 24 hr after electroporation. Monoclonal cell lines were identified by Western blot and immunocytochemistry.

Cells were cultured in Ibidi μ-slides (Ibidi, Planegg, Germany) attached to a home-built gravity-flow perfusion system. Measurements were performed using a CellR live-cell imaging system (Olympus) with 20x objective. Cells were perfused with extracellular solution (ES: 120 mM NaCl, 5 mM KCl, 2 mM MgCl~2~, 2 mM CaCl~2~, 10 mM HEPES, 10 mM glucose, pH 7.4) to determine the basal FRET ratio and then the stimulus was added (NKH477 and IBMX, Tocris, Wiesbaden, Germany; Isoproterenol and SNP, Sigma-Aldrich). FRET was recorded by exciting cerulean at 436 nm and measuring the emission of cerulean and citrine at 470 nm and 535 nm, respectively. The change in FRET (emission~cerulean~/emission~citrine~) was calculated, corrected for bleed-through, normalized to the baseline, and plotted versus time.

For population measurement using a spectrofluorometer (Quantamaster 40, PTI), HEK293 cells were trypsinized at 37°C for 5 min and washed twice with ES. Measurements were performed in PMMA cuvettes at 1x10^5^ cells/ml under constant stirring (Spinbar, Bel-art products, Wayne, NJ). Fluorescence spectra at steady-state were recorded with excitation at 430 nm and 0.5 s integration time. For time-resolved measurements, cells were excited at 430 nm and emission was recorded at 470 nm (cerulean) and 530 nm (citrine) at an acquisition frequency of 1 Hz. The change in FRET (emission~cerulean~/emission~citrine~) was calculated, corrected for bleed-through, normalized to the baseline, and plotted versus time.

For repetitive stimulation experiments, cells were stimulated with 500 nM isoproterenol and fluorescence was measured in a plate reader (FLUOstar Omega; BMGLabtech) at 29°C with excitation at 440 nm and emission at 485 and 520 nm. The wash-out was performed by removing the stimulus and addition of ES. The fluorescence emission ratio was normalized to the initial baseline fluorescence ratio and plotted as a function of time.

Generation and genotyping of *Prm1*-mlCNBD-FRET transgenic mice {#s4-7}
---------------------------------------------------------------

A hemagglutinin (HA) tag was fused to the C-terminus, an *EcoRI* restriction site was added to the 5' end, the internal *BamH*I site was deleted, and a *BamH*I and *Xba*I restriction site was added to the 3' end by PCR. The PCR product was cloned into a pBluescript SK- vector (Agilent Technologies, Santa Clara, USA) using *EcoR*I and *Xba*I (pB-mlCNBD-FRET). After sequencing, the mlCNBD-FRET-HA insert was excised and cloned into pPrCExV (kind gift from Robert Braun, Jackson Laboratory) using *BamH*I (pPrCExV-mlCNBD-FRET) to express mlCNBD-FRET under the control of the protamine-1 promotor that is exclusively active in post-meiotic spermatids ([@bib91]). Transgenic mice were generated via pronuclear injection following standard procedures ([@bib38]) at the transgenic facility of the LIMES (University of Bonn, Germany; licence number: 84--02.04.2012.A192). Mice were genotyped by PCR using mlCNBD-FRET-specific primers (\#1: 5'-GTACAAGGGTACCCAAGAAGTCCGTCGC-3', \#2: 5'-CGAAGCACTGCACGCCCCAGGTC-3'). Mice used in this study were 2--5 months of age. All animal experiments were in accordance with the relevant guidelines and regulations.

Western blot analysis {#s4-8}
---------------------

Protein lysates were obtained by homogenizing cells or tissue in lysis buffer (10 mM Tris/HCl, pH 7.6, 140 mM NaCl, 1 mM EDTA, 1% Triton X-100, mPIC protease inhibitor cocktail 1:500) followed by trituration through a 18-gauge needle. Samples were incubated for 30 min on ice and centrifuged at 10,000 g for 5 min at 4°C. Prior to separation by SDS-PAGE, samples were mixed with 4x SDS loading-buffer (200 mM Tric/HCl, pH 6.8, 8% SDS (w/v), 4% β-mercaptoethanol (v/v), 50% glycerol, 0.04% bromophenol blue) and heated for 5 min at 95°C. Sperm samples used for SDS-PAGE were washed with 1 ml PBS and sedimented by centrifugation at 5000 g for 5 min. 1--2 x 10^6^ cells were resuspended in 4 x SDS loading buffer and heated for 5 min at 95°C. For Western-blot analysis, proteins were transferred onto PVDF membranes (Merck Millipore, Billerica, USA), probed with antibodies, and analysed using the Odyssey Imaging System (LI-COR, Lincoln, NE) detection-system.

Primary antibodies: anti-HA 3F10 (1:5000; Roche, Basel, Switzerland), anti-α-tubulin (1:5000; Sigma-Aldrich) anti-GFP antibody (1:5000; abcam, Cambridge, UK); secondary antibodies: IRDye680 and IRDye800 antibodies (1:20,000, LI-COR); ICC: fluorescently-labeled antibodies (1:500; Dianova, Hamburg, Germany).

Immunohistochemistry {#s4-9}
--------------------

Testes were fixed in 4% paraformaldehyde/PBS overnight, cryo-protected in 10 and 30% sucrose, and embedded in Tissue-Tek (Sakura Finetek, Alphen aan den Rijn, Netherlands). To block unspecific binding sites, cryosections (16 µm) were incubated for 1 hr with blocking buffer (0.5% Triton X-100 and 5% ChemiBLOCKER (Merck Millipore) in 0.1 M NaP, pH 7.4). The primary anti-HA 3F10 antibody (rat monoclonal; Roche, Basel, Switzerland) was diluted 1:1000 in blocking buffer and incubated for 2 hr. Fluorescent secondary antibodies (donkey anti-rat CY3; Dianova) were diluted 1:500 in blocking buffer containing 0.5 mg/ml DAPI (Life Technologies) and pictures were taken on a confocal microscope (FV1000; Olympus).

Sperm preparation {#s4-10}
-----------------

Sperm were isolated by incision of the cauda followed by a swim-out in modified TYH medium (135 mM NaCl, 4.8 mM KCl, 2 mM CaCl~2~, 1.2 mM KH~2~PO~4~, 1 mM MgSO~4~, 5.6 mM glucose, 0.5 mM sodium pyruvate, 10 mM L-lactate, 10 mM HEPES, pH 7.4). For capacitation, the medium contained 3 mg/ml BSA and 25 mM of NaCl was substituted with 25 mM NaHCO~3~. The pH was adjusted at 37°C. After 15--30 min swim-out at 37°C, sperm were collected and counted.

Fluorescence spectroscopy to measure cAMP dynamics in sperm populations {#s4-11}
-----------------------------------------------------------------------

After swim-out, sperm were kept in 500 μl tubes filled up with TYH buffer to avoid pH changes due to dissolution of ambient CO~2~ into the buffer. Measurements were performed in TYH buffer containing 1--5 x 10^4^ sperm/ml. The fluorescence recording was performed at a spectrofluorometer (Quantamaster 40, PTI) at 37°C as described for the mammalian cells lines.

Nominally Ca^2+^-free TYH buffer was prepared by adding 10 μM Ca^2+^ to TYH buffer prepared without any Ca^2+^. When adding 25 mM NaHCO~3~ (1:10 from 250 mM stock), the Na^+^ concentration in modified TYH was reduced to 110 mM NaCl. BAPTA (1,2-Bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid tetrapotassium salt, Sigma-Aldrich) was dissolved in the modified TYH buffer (pH 7.4) and added to sperm samples at a final concentration of 1, 2, or 3 mM.

Intracellular pH measurement with BCECF {#s4-12}
---------------------------------------

Cells were loaded with 10 μM (HEK293 cells) or 5 μM BCECF-AM (sperm) (Invitrogen) for 10 min at 37°C and 10% CO~2~. Afterwards, HEK293 cells were washed three times in 1 ml ES before starting the measurement. For sperm, the dye was removed by single centrifugation (700 x g, 7 min, RT) and resuspension in TYH buffer. For HEK293 cells, fluorescence was measured in a plate reader (FLUOstar Omega; BMGLabtech) at 29°C. For calibrating the intracellular pH (pH~i~) using the null-point method, cells were permeabilized with Triton‐X 100 (final concentration of 0.1% ) followed by addition of different pH buffer solutions (pH 5--8). BCECF was excited at 440 nm and 485 nm and the emission was detected at 520 nm. The fluorescence emission ratio at both excitation channels was normalized to the initial fluorescence ratio and plotted as a function of pH. A linear regression analysis (Origin; OriginLab) was performed to calculate the pH~i~.

Changes in pH~i~ in sperm were either analysed in a rapid-mixing device (SFM-400; Biologic) in the stopped-flow mode or in a spectrofluorometer (Quantamaster 40, PTI) at 37°C. In the stopped-flow device, the sperm suspension (5·10^6^ sperm/ml) was rapidly mixed 1:1 (v/v) at a flow rate of 0.5 ml/s with the respective stimulants. Fluorescence was excited by a SpectraX Light Engine (Lumencor), whose intensity was modulated with a frequency of 10 kHz. The excitation light was passed through a BrightLine 452/45 nm filter (Semrock) onto the cuvette (FC-15, Biologic). Emission light was recorded in a dual-emission mode using BrightLine 494/20-nm and BrightLine 540/10-nm filters (Semrock) by photomultiplier modules (H10723-20; Hamamatsu Photonics). The signal was amplified and filtered through a lock-in amplifier (7230 DualPhase, Ameteky). Data acquisition was performed with a data acquisition pad (PCI-6221; National Instruments) and Bio-Kine software v. 4.49 (Bio-Logic, Illingen, Germany). The pH signal represent the ratio of F494/540 and is depicted as the percent of the relative change in ratio (Δ*R/R*) with respect to the mean of the first three data points at the onset of the signal. The control (TYH) signal was subtracted from the NH~4~Cl or bicarbonate traces.

To analyze the effect of changing the extracellular Ca^2+^ on the intracellular pH, measurements were performed at the spectrofluorometer in respective TYH buffer containing 1 x 10^4^ sperm/ml. BAPTA (1,2-Bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid tetrapotassium salt, Sigma-Aldrich) was dissolved in the modified TYH buffer (pH 7.4) and added to the sperm samples at a final concentrations of 3 mM. BCECF was excited at 452 nm and the emission was detected at 494 nm and 540 nm. The fluorescence emission ratio of 540/494 was calculated and plotted against time. The ratio was corrected for a drift in fluorescence. The drift was determined by calculating the slope of the response after addition of buffer experiment, which was multiplied to the time axis to calculate the drift over time. The drift was subtracted from the sample data. The drift corrected data was finally normalized to the initial emission ratio.

Determination of total cAMP content {#s4-13}
-----------------------------------

After stimulation with 25 mM NaHCO~3~, the reaction was quenched with HClO~4~ (1:3 (v/v); 0.5 M final concentration). Samples were frozen in liquid N~2~, thawed, and neutralized by addition of K~3~PO~4~ (0.24 M final concentration). The salt precipitate and cell debris were sedimented by centrifugation (15 min, 15,000 g, 4°C). The cAMP content in the supernatant was determined by a competitive immunoassay (Molecular Devices, Sunnyvale, CA) including an acetylation step for higher sensitivity. Calibration curves were obtained by serial dilutions of cAMP standards. 96-well plates were analysed by using a microplate reader (FLUOstar Omega; BMGLabtech).

Calibration of the FRET sensor in HEK293 cells {#s4-14}
----------------------------------------------

To determine the basal concentration of cAMP in HEK293 cells, the null-point method was used. HEK293 cells stably expressing mlCNBD-FRET were trypsinized and cells were suspended in 1 ml ES buffer (5 x 10^5^ cells/ml). The fluorescence was recorded for 5 min in a spectrofluorometer (Quantamaster 40, PTI) with excitation at 430 nm and emission at 471 nm (cerulean) and 529 nm (citrine). Cells were then permeabilized with 20 μM digitonin to deplete intracellular cAMP and the concomitant FRET signal was measured. During permeabilization, the pH~i~ might change if the extracellular and intracellular pH is different. Using the pH indicator BCECF, we determined a pH~i~ of 7.2 ± 0.1 (n = 4) in mlCNBD-FRET-expressing HEK293 cells. Accordingly, we set pH~o~ during permeabilization to 7.2 to assure that no pH change occurs. Increasing concentrations of cAMP were then added to the cell suspension that eventually saturate the FRET sensor. The FRET ratio for each cAMP concentration was plotted against the cAMP concentrations and analysed by linear regression. The basal cAMP concentration was defined as the external cAMP concentration where no change in FRET was observed.

Multi-photon fluorescence lifetime microscopy (FLIM) {#s4-15}
----------------------------------------------------

The decay of the fluorescence lifetime was measured on a Trimscope II (LaVision BioTec, Göttingen, Germany) equipped with a FLIM x16 TCSPC detector. Cells were imaged using a 20x NA = 1.0 water-dipping objective and excited with an 80 MHz mode-locked laser tuned to 810 nm. Emitted photons were filtered through a 700 nm short-pass filter followed by a 495 nm dichroic mirror that reflected the fluorescence below 488 nm towards the FLIM detector. Images were acquired with 512x512 pixels, pixel size = 800 nm. The instrument response function (IRF) was obtained from second harmonic signals generated from a urea sample at the same excitation wavelength. Cells were imaged in ES in culture dishes at 23°C. To increase the intracellular cAMP concentration, cells were stimulated for 5 min using 40 µM NKH/500 μM IBMX. As a control, 0.05% DMSO was used. To permeabilize the cells and reduce the intracellular cAMP concentration, cells were treated with 20 μM digitonin for 10 min. To measure the maximal response, cells were incubated with 5 μM cAMP. Time constants of fluorescence decay were calculated using the FLIMfit software tool ([@bib80]). The fitting function consisted of a double exponential decay model that was convolved with the IRF. Pixels below 20 counts were excluded from the analysis. 15x15 pixels were then binned to increase photon count and improve the accuracy of the fit. The analysis generated two time constants ($\tau_{1}$ and $\tau_{2}$) associated with the double exponential decay. Individual amplitudes (a~1~ and a~2~) reflecting the magnitude of each decay constant were used to calculate the weighted average $\tau_{average}$ for every pixel using the following equation:$$\tau_{average} = \operatorname{}\frac{a_{1} \times \tau_{1} + a_{2} \times \tau_{2}}{a_{1} + a_{2}}$$

Fluorescence lifetime spectroscopy {#s4-16}
----------------------------------

Decay curves were recorded by Time-Correlated Single-Photon Counting (TCSPC) using the FluoTime 300 (PicoQuant). Cells in solution (10^6^ cells/ml in ES) or purified protein (1 μM) were measured in a cuvette and excited by a pulsed diode laser at 440 nm (PicoQuant) and fluorescence emission was detected at 480/20 nm. The IRF was obtained using Ludox suspension. The cerulean lifetime decay was measured for cells in ES before stimulation with 40 µM NKH/500 µM IBMX. Cells were suspended in 1 ml ES in a cuvette. To calibrate mlCNBD-FRET in cells using FLS, the decay of the cerulean lifetime was first recorded in ES followed by the addition of 20 µM digitonin to permeabilize the cells and then by addition of increasing cAMP concentrations. Fitting was performed using the PicoQuant FluoFit software. A double-exponential function was chosen for the analysis with iterative reconvolution using the IRF obtained from Ludox.

Cloning ciliary constructs {#s4-17}
--------------------------

The full-length mouse SSTR3 cloned into pEGFP-N1 was kindly provided by Greg Pazour (UMass Medical School). For expression of SSTR3-tagged mlCNBD-FRET, the SSTR3 coding sequence was amplified by a recombinant PCR reaction to delete the internal *NheI* site. The fragment was subcloned into pc3.1-mlCNBD-FRET vie *NheI/HindIII*.

Acceptor photobleaching {#s4-18}
-----------------------

During acceptor photobleaching, the fluorescence of the FRET donor is recorded while bleaching the FRET acceptor. IMCD-3 cells (ATCC CRL-2123, authentication method: STR profiling, mycoplasma test negative) were transfected with pc3.1-SSTR3-mlCNBD-FRET using the Neon 100 µl kit (Invitrogen) and the MicroPorator (Digital Bio) according to the manufacture's protocol. Afterwards, cells were plated on coverslips and the experiment was performed on an inverted microscope (eclipse Ti, Nikon, Düsseldorf, Germany), equipped with EMCCD camera (iXON Ultra 897, Andor, Berlin, Germany), using 100x oil objective (CFI Apo TIRF, NA 1.49, Nikon). First, an image of the cilium was obtained in the donor channel using 405 nm laser excitation and 480/40 nm emission and an image in the acceptor channel using 488 nm laser excitation and 560/40 nm emission. Photobleaching was performed at 510/20 nm using a mercury lamp (C-LHGFIE, Nikon) for 2 min. This was followed by the acquisition of two images, one in the donor channel and another in the acceptor channel. The donor channel was compared to the images before and after acceptor photobleaching and the increase in intensity was quantified after background subtraction. The amount of bleaching was assessed by comparing citrine fluorescence before and after bleaching.

FRET measurement using dual-view imaging {#s4-19}
----------------------------------------

For spatial-temporal-resolved measurements, sperm from transgenic mice were imaged with a dual-view microscopic setup. Cerulean was excited at 440/20 nm (Lumencor Spectra X light engine) combined with a 438/24 nm excitation filter (Semrock). In addition, a dichroic mirror 455 nm DRLP and an additional filter with 460 nm ALP (Edmund optics, Karlsruhe, Germany) was used. Emission light was collected with an objective (40x, NA 0.95; Olympus, USA) and detected with an EMCCD Camera (iXon Ultra 897, Andor). In the dual-view emission path, a beam splitter (DV2, 515 dxcr, Mag Biosystems, Exton, PA) with a cerulean and citrine emission filter (475/28 nm and 535/50 nm, respectively; Semrock) was used. Thereby, both channels were acquired simultaneously with an acquisition frequency of 1 Hz. The resulting video was analyzed with a self-developed image analysis plugin for ImageJ. First, the citrine and the cerulean channel was registered (MultiStackReg, ImageJ). Second, the flagellum was tracked and the signal intensity of the citrine and the cerulean channel was determined along the flagellum. By using the pre-determined bleed-through value for the citrine channel (0.69 ± 0.01), changes in FRET ((emission~cerulean~ -- 0.69 x emission~citrine~)/emission~citrine~) was calculated, normalized to the baseline, and plotted versus time for each position along the arc length. The droplet separates the midpiece and the principal piece; thus, both regions were selected at a distance 5--10 µm apart from the droplet. The mean signal intensity and the standard deviation was determined in both regions for 20 µm along the arc length. The values were plotted over time and a logistic regression (Origin 9.0) was used to determine the kinetics within the two regions. The parameters of the logistic regression for different experiments were used to determine the average kinetics within the two regions.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your work entitled \"A novel biosensor to study cAMP dynamics in cilia and flagella\" for consideration by *eLife*. Your article has been favorably evaluated by Richard Aldrich (Senior editor) and three reviewers, one of whom, (David Clapham) is a member of our Board of Reviewing Editors.

The following individuals involved in review of your submission have agreed to reveal their identity: Aldeberan Hofer and Dejian Ren (peer reviewers).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

*Mloti*K1 channel that binds cAMP with K~d~\~ 70 nM and cGMP with K~d~\~500 nM. They generate transgenic mice expressing it in sperm flagellae and primary cilia. The results suggest that free cAMP in the flagellum is distinct from that in midpiece or head, and is dominated by soluble bicarbonate-stimulated adenylyl cyclase (AC10). This is a useful tool for monitoring free cAMP in sperm and cilia. This work is exciting because it represents a completely new type of cAMP sensor that doesn\'t rely on sequences from mammalian PKA, Epac or cyclic nucleotide-gated channels. An important feature of mlCNBD-FRET is its high affinity for cAMP. Null-point calibration estimated that resting cytosolic cAMP is around 35nM. This is perhaps the first accurate measurement of resting free cAMP, although this may reflect a mixture of resting cGMP and cAMP. Another useful feature is that the sensor protein can be isolated and used *in vitro* to monitor cAMP. The experiments in sperm cell and cilia nicely demonstrated the feasibility of using the probe *in vivo*, but these studies are preliminary and yielded less well-supported new information. All reviewers felt the paper was most appropriate as a \'Tools and Resource\' paper.

1\) The authors should extend the range of changes in K~d~ for cAMP binding to pH 8, since this can be achieved in alkaline environments in sperm flagella. Also the results with 25mM NaHCO~3~ are ambiguous. [Figure 2F](#fig2){ref-type="fig"} indicates a strange pH sensitivity of the reporter, and it\'s not certain how pH changes upon NaHCO~3~ addition. A control experiment to measure pH upon NaHCO~3~ treatment, and an independent test of FRET changes of mlCNBD-FRET using a maneuver known to change pH in a defined manner (e.g. NH3 or lactate) would be helpful. Does the cAMP-insensitive mlCNBD-FRET-R307Q respond to NaHCO~3~? One reviewer noted that in [Figure 7B, D](#fig7){ref-type="fig"}, in the experiments where \[Ca^2+^\]~o~ is manipulated, the authors interpret the changes of FRET signals as changes in \[cAMP\]. It is possible that the reduction/increase in \[Ca^2+^\]~o~ also changes intracellular pH or \[Ca^2+^\], which in turn affects the FRET signal independent of changes in \[cAMP\] ([Figure 2F](#fig2){ref-type="fig"}). A simple \"negative\" control is perhaps to repeat the experiment in the presence of NKH477. The inhibitor presumably should also block the FRET changes induced by increases in \[Ca^2+^\]~o~.

2\) The data presented indicate that mlCNBD-FRET has quite high affinity for cAMP (66nM purified protein, 73nM in situ in cells) and is saturated at around 3µM cAMP. Of note, the probe also has relatively high affinity for cGMP (504nM), which is similar to some other reporters designed expressly for this purpose. The high affinity for cAMP is very useful for assessing subtle variations in resting cAMP, but is buffering of cAMP a problem? Although Prm1-mICNBD-FRET males were fertile, was flagellar beating altered by the expression of mlCNBD-FRET?

3\) [Figure 3](#fig3){ref-type="fig"} demonstrates that the biosensor works well when expressed in HEK cells. However, only maneuvers expected to saturate the sensor are shown. Since low affinity probes based on Epac are also saturated by these treatments that produce massive amounts of cAMP (probably 50- 100µM), it is not surprising that mICNBD-FRET also becomes saturated. It would be nice to see the response to physiological stimulation with sub-maximal agonist concentrations, and also the reversibility of the probe (not by permeabilization with digitonin, but through PDE activity). [Figure 3G](#fig3){ref-type="fig"} shows that the cAMP-insensitive mlCNBD-FRET-R307Q also demonstrates a modest decrease when digitonin is applied, calling into question whether the decreased baseline shown for the parent sensor reflects a true decrease in cAMP/cGMP below baseline.

4\) The FLIM data are weak, with cerulean lifetime changes only from 2.44+/-02 to 2.38 +/-04 ns after large change in free cAMP. We suggest stating the FLIM data, but pointing out that it is not very suited to FLIM, unless the authors are able to obtain much more data supporting this claim. Thus that section of the figure can be removed.
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Author response

1\) The authors should extend the range of changes in K~d~ for cAMP binding to pH 8, since this can be achieved in alkaline environments in sperm flagella.

We have performed additional cAMP binding studies at pH 8 to determine the K~d~. The K~d~ at pH 8 is 50 ± 13 nM, indicating that the affinity for cAMP increases upon alkalization. Of note, it has been reported for other CNBDs that the affinity for cAMP depends on the pH (Gordon et al., 1996; Kaupp & Seifert, 2002). The information has also been included in the manuscript and the text has been changed accordingly.

Also the results with 25mM NaHCO~3~ are ambiguous. [Figure 2F](#fig2){ref-type="fig"} indicates a strange pH sensitivity of the reporter, and it\'s not certain how pH changes upon NaHCO~3~ addition. A control experiment to measure pH upon NaHCO~3~ treatment, and an independent test of FRET changes of mlCNBD-FRET using a maneuver known to change pH in a defined manner (e.g. NH3 or lactate) would be helpful. Does the cAMP-insensitive mlCNBD-FRET-R307Q respond to NaHCO~3~?

To test whether NaHCO~3~ evokes a change in the intracellular pH~i~, we measured changes in pH~i~ using BCECF in wild-type mouse sperm after stimulation with NaHCO~3~ and after stimulation with NH~4~Cl as a control. Stimulation with NH~4~Cl evoked a pronounced alkalization and, in turn, decreased the FRET ratio ([Figure 5---figure supplement 1A, B](#fig5s1){ref-type="fig"}). The kinetics of both changes were similar, indicating that the change in FRET is evoked by the change in pH~i~. In contrast, stimulation with NaHCO~3~ only evoked a miniscule and slow change in pH~i~ ([Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}) that was not comparable to the rapid changes in FRET ratio after bicarbonate stimulation (see [Figure 6C](#fig6){ref-type="fig"}). These results support the notion that the changes in FRET evoked by NaHCO~3~ reflect changes in cAMP rather than pH~i~.

One reviewer noted that in [Figure 7B, D](#fig7){ref-type="fig"}, in the experiments where \[Ca^2+^\]~o~ is manipulated, the authors interpret the changes of FRET signals as changes in \[cAMP\]. It is possible that the reduction/increase in \[Ca^2+^\]~o~ also changes intracellular pH or \[Ca^2+^\], which in turn affects the FRET signal independent of changes in \[cAMP\] ([Figure 2F](#fig2){ref-type="fig"}). A simple \"negative\" control is perhaps to repeat the experiment in the presence of NKH477. The inhibitor presumably should also block the FRET changes induced by increases in \[Ca^2+^\]~o~.

To test whether \[Ca^2+^\]~o~ affects the intracellular pH, we measured pH~i~ using BCECF in wild-type mouse sperm after increasing or decreasing \[Ca^2+^\]~o~. As a control, sperm were stimulated with NH~4~Cl, which evoked a pronounced alkalization and, in turn, decreased the FRET ratio ([Figure 5---figure supplement 1A, B](#fig5s1){ref-type="fig"}). Reducing \[Ca^2+^\]~o~ to 443 nM by addition of 3 mM BAPTA did not change the intracellular pH ([Figure 7F](#fig7){ref-type="fig"}).

We are sorry, but we do not understand the suggestion using NKH477. NKH477 is an activator (not inhibitor) of tmACs that are absent in sperm flagella; NKH477 has no effect on sperm cAMP levels (see [Figure 6B](#fig6){ref-type="fig"}).

2\) The data presented indicate that mlCNBD-FRET has quite high affinity for cAMP (66nM purified protein, 73nM in situ in cells) and is saturated at around 3µM cAMP. Of note, the probe also has relatively high affinity for cGMP (504nM), which is similar to some other reporters designed expressly for this purpose. The high affinity for cAMP is very useful for assessing subtle variations in resting cAMP, but is buffering of cAMP a problem? Although Prm1-mICNBD-FRET males were fertile, was flagellar beating altered by the expression of mlCNBD-FRET?

This argument is well taken. As the reviewer also pointed out, Prm1-mlCNBD-FRET males are fertile, indicating that sperm function is not severely altered by the sensor. The flagellar beat frequency of wild-type and transgenic sperm was similar: wild-type: 8.4 ± 2.1 Hz, n = 8, 58 cells total; mlCNBD -FRET: 7.3 ± 3.0 Hz, n = 4, 40 cells total. The information has been added to [Figure 4---source data 1](#SD1-data){ref-type="supplementary-material"}.

*3) [Figure 3](#fig3){ref-type="fig"} demonstrates that the biosensor works well when expressed in HEK cells. However, only maneuvers expected to saturate the sensor are shown. Since low affinity probes based on Epac are also saturated by these treatments that produce massive amounts of cAMP (probably 50- 100µM), it is not surprising that mICNBD-FRET also becomes saturated. It would be nice to see the response to physiological stimulation with sub-maximal agonist concentrations, and also the reversibility of the probe (not by permeabilization with digitonin, but through PDE activity).*

We agree. Accordingly, we performed a dose-response relationship for stimulation with NKH477 to activate the tmACs. The EC50 for NKH477 is 3.6 ± 0.6 µM (n = 4). This data set has been included in [Figure 3---figure supplement 1F](#fig3s1){ref-type="fig"}.

To show the reversibility of the sensor, we have alternatingly stimulated cells with isoproterenol followed by a wash-out with buffer. After wash-out, the FRET ratio was lowered and increased again after stimulation with isoproterenol, demonstrating the reversibility of the sensor. This data set has also been included in [Figure 3---figure supplement 1G](#fig3s1){ref-type="fig"}.

[Figure 3G](#fig3){ref-type="fig"} shows that the cAMP-insensitive mlCNBD-FRET-R307Q also demonstrates a modest decrease when digitonin is applied, calling into question whether the decreased baseline shown for the parent sensor reflects a true decrease in cAMP/cGMP below baseline.

The mlCNBD-FRET-R307Q mutant has been generated as a control to visualize any unspecific effects on the FRET ratio that are independent of cAMP. The small decrease in baseline for the mlCNBD-FRET-R307Q mutant is probably due to a permeabilization artefact. However, [Figure 3G](#fig3){ref-type="fig"} shows a larger decline of the FRET ratio after permeabilization with digitonin from the plateau that is reached after stimulation with NKH477.

4\) The FLIM data are weak, with cerulean lifetime changes only from 2.44+/-02 to 2.38 +/-04 ns after large change in free cAMP. We suggest stating the FLIM data, but pointing out that it is not very suited to FLIM, unless the authors are able to obtain much more data supporting this claim. Thus that section of the figure can be removed.

Although the changes in cerulean lifetime in the FLIM measurements are relatively small, they are nonetheless significant. To the best of our knowledge, such FLIM measurements with cAMP FRET sensors have not yet been reported. Thus, we prefer to leave this figure as it is. However, we have rephrased the text to: "In summary, mlCNBD-FRET is an exquisitely sensitive biosensor for measuring cAMP dynamics in the nanomolar range, preferably using fluorescence intensity techniques, but also using lifetime-based techniques."

[^1]: These authors contributed equally to this work.
